Prudential plc’s Amedisys AMED Stock Holding History

Prudential plc’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,959	Closed	-$229K	–	651
2018 Q4	$229K	Buy	+1,959	New	+$231K	﹤0.01%	642

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc's AMED Position: Q1 2019 in Review

Prudential plc sold out of Amedisys (AMED) in Q1 2019, closing a stake of 1,959 shares — an estimated $229K sold.

Prudential plc first reported a position in AMED in Q4 2018 and held it in 1 quarter. The position peaked at $229K in Q4 2018. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

Prudential plc reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
Prudential plc sold 1,959 Amedisys shares in Q1 2019, an estimated $229K.
Prudential plc first reported a position in Amedisys in Q4 2018 and held it in 1 quarter.
Prudential plc's Amedisys position peaked at $229K in Q4 2018.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on Prudential plc's 13F filing for Q1 2019, filed 13 May 2019.